世界の免疫細胞療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Immuno-Cell Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4351
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、117ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、免疫細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（受動免疫（NK、LAKなど）、能動免疫）、用途別市場規模（腫瘍学、心血管疾患（CVD）、整形外科、創傷治癒、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・免疫細胞療法の市場動向
・企業の競争状況、市場シェア
・免疫細胞療法の種類別市場規模と予測2016-2027（受動免疫（NK、LAKなど）、能動免疫）
・免疫細胞療法の用途別市場規模と予測2016-2027（腫瘍学、心血管疾患（CVD）、整形外科、創傷治癒、その他）
・免疫細胞療法の北米市場規模2016-2027（アメリカ、カナダ）
・免疫細胞療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・免疫細胞療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・免疫細胞療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・免疫細胞療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（MEDINET Co、Erytech、Seta Clinic Group、Takeda、SBI Holdings、Oxford BioTherapeutics、Fate Therapeutics、Gilead Sciences、Novartis、Osiris、Vericel Corporation、Fujifilm Cellular Dynamics、JCR Pharmaceuticals、Beike Biotechnology、Golden Meditech、Guanhao Biotech、Beroni Group）
・結論

Immuno-Cell Therapy is known as a systemic treatment with minimal adverse reaction in cancer treatment. Basic concept of the therapy is to strengthen immune function of human body for elimination of any abnormal cells such as virus-infected or malignant cells from the body.

Market Analysis and Insights: Global Immuno-Cell Therapy Market
The global Immuno-Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immuno-Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immuno-Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immuno-Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immuno-Cell Therapy market.

Global Immuno-Cell Therapy Scope and Market Size
Immuno-Cell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immuno-Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Passive Immune (NK, LAK etc)
Active Immune

Segment by Application
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Passive Immune (NK, LAK etc)
1.2.3 Active Immune
1.3 Market by Application
1.3.1 Global Immuno-Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Cardiovascular Disease (CVD)
1.3.4 Orthopedic
1.3.5 Wound Healing
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Immuno-Cell Therapy Market Perspective (2016-2027)
2.2 Immuno-Cell Therapy Growth Trends by Regions
2.2.1 Immuno-Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immuno-Cell Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Immuno-Cell Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Immuno-Cell Therapy Industry Dynamic
2.3.1 Immuno-Cell Therapy Market Trends
2.3.2 Immuno-Cell Therapy Market Drivers
2.3.3 Immuno-Cell Therapy Market Challenges
2.3.4 Immuno-Cell Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Immuno-Cell Therapy Players by Revenue
3.1.1 Global Top Immuno-Cell Therapy Players by Revenue (2016-2021)
3.1.2 Global Immuno-Cell Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Immuno-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immuno-Cell Therapy Revenue
3.4 Global Immuno-Cell Therapy Market Concentration Ratio
3.4.1 Global Immuno-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Cell Therapy Revenue in 2020
3.5 Immuno-Cell Therapy Key Players Head office and Area Served
3.6 Key Players Immuno-Cell Therapy Product Solution and Service
3.7 Date of Enter into Immuno-Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Immuno-Cell Therapy Breakdown Data by Type
4.1 Global Immuno-Cell Therapy Historic Market Size by Type (2016-2021)
4.2 Global Immuno-Cell Therapy Forecasted Market Size by Type (2022-2027)

5 Immuno-Cell Therapy Breakdown Data by Application
5.1 Global Immuno-Cell Therapy Historic Market Size by Application (2016-2021)
5.2 Global Immuno-Cell Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Immuno-Cell Therapy Market Size (2016-2027)
6.2 North America Immuno-Cell Therapy Market Size by Type
6.2.1 North America Immuno-Cell Therapy Market Size by Type (2016-2021)
6.2.2 North America Immuno-Cell Therapy Market Size by Type (2022-2027)
6.2.3 North America Immuno-Cell Therapy Market Size by Type (2016-2027)
6.3 North America Immuno-Cell Therapy Market Size by Application
6.3.1 North America Immuno-Cell Therapy Market Size by Application (2016-2021)
6.3.2 North America Immuno-Cell Therapy Market Size by Application (2022-2027)
6.3.3 North America Immuno-Cell Therapy Market Size by Application (2016-2027)
6.4 North America Immuno-Cell Therapy Market Size by Country
6.4.1 North America Immuno-Cell Therapy Market Size by Country (2016-2021)
6.4.2 North America Immuno-Cell Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Immuno-Cell Therapy Market Size (2016-2027)
7.2 Europe Immuno-Cell Therapy Market Size by Type
7.2.1 Europe Immuno-Cell Therapy Market Size by Type (2016-2021)
7.2.2 Europe Immuno-Cell Therapy Market Size by Type (2022-2027)
7.2.3 Europe Immuno-Cell Therapy Market Size by Type (2016-2027)
7.3 Europe Immuno-Cell Therapy Market Size by Application
7.3.1 Europe Immuno-Cell Therapy Market Size by Application (2016-2021)
7.3.2 Europe Immuno-Cell Therapy Market Size by Application (2022-2027)
7.3.3 Europe Immuno-Cell Therapy Market Size by Application (2016-2027)
7.4 Europe Immuno-Cell Therapy Market Size by Country
7.4.1 Europe Immuno-Cell Therapy Market Size by Country (2016-2021)
7.4.2 Europe Immuno-Cell Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Immuno-Cell Therapy Market Size (2016-2027)
8.2 Asia-Pacific Immuno-Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Immuno-Cell Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Immuno-Cell Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Immuno-Cell Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Immuno-Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Immuno-Cell Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Immuno-Cell Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Immuno-Cell Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Immuno-Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Immuno-Cell Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immuno-Cell Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Immuno-Cell Therapy Market Size (2016-2027)
9.2 Latin America Immuno-Cell Therapy Market Size by Type
9.2.1 Latin America Immuno-Cell Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Immuno-Cell Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Immuno-Cell Therapy Market Size by Type (2016-2027)
9.3 Latin America Immuno-Cell Therapy Market Size by Application
9.3.1 Latin America Immuno-Cell Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Immuno-Cell Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Immuno-Cell Therapy Market Size by Application (2016-2027)
9.4 Latin America Immuno-Cell Therapy Market Size by Country
9.4.1 Latin America Immuno-Cell Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Immuno-Cell Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Immuno-Cell Therapy Market Size (2016-2027)
10.2 Middle East & Africa Immuno-Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Immuno-Cell Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Immuno-Cell Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Immuno-Cell Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Immuno-Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Immuno-Cell Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Immuno-Cell Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Immuno-Cell Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Immuno-Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Immuno-Cell Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immuno-Cell Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 MEDINET Co
11.1.1 MEDINET Co Company Details
11.1.2 MEDINET Co Business Overview
11.1.3 MEDINET Co Immuno-Cell Therapy Introduction
11.1.4 MEDINET Co Revenue in Immuno-Cell Therapy Business (2016-2021)
11.1.5 MEDINET Co Recent Development
11.2 Erytech
11.2.1 Erytech Company Details
11.2.2 Erytech Business Overview
11.2.3 Erytech Immuno-Cell Therapy Introduction
11.2.4 Erytech Revenue in Immuno-Cell Therapy Business (2016-2021)
11.2.5 Erytech Recent Development
11.3 Seta Clinic Group
11.3.1 Seta Clinic Group Company Details
11.3.2 Seta Clinic Group Business Overview
11.3.3 Seta Clinic Group Immuno-Cell Therapy Introduction
11.3.4 Seta Clinic Group Revenue in Immuno-Cell Therapy Business (2016-2021)
11.3.5 Seta Clinic Group Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Immuno-Cell Therapy Introduction
11.4.4 Takeda Revenue in Immuno-Cell Therapy Business (2016-2021)
11.4.5 Takeda Recent Development
11.5 SBI Holdings
11.5.1 SBI Holdings Company Details
11.5.2 SBI Holdings Business Overview
11.5.3 SBI Holdings Immuno-Cell Therapy Introduction
11.5.4 SBI Holdings Revenue in Immuno-Cell Therapy Business (2016-2021)
11.5.5 SBI Holdings Recent Development
11.6 Oxford BioTherapeutics
11.6.1 Oxford BioTherapeutics Company Details
11.6.2 Oxford BioTherapeutics Business Overview
11.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Introduction
11.6.4 Oxford BioTherapeutics Revenue in Immuno-Cell Therapy Business (2016-2021)
11.6.5 Oxford BioTherapeutics Recent Development
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Details
11.7.2 Fate Therapeutics Business Overview
11.7.3 Fate Therapeutics Immuno-Cell Therapy Introduction
11.7.4 Fate Therapeutics Revenue in Immuno-Cell Therapy Business (2016-2021)
11.7.5 Fate Therapeutics Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Immuno-Cell Therapy Introduction
11.8.4 Gilead Sciences Revenue in Immuno-Cell Therapy Business (2016-2021)
11.8.5 Gilead Sciences Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-Cell Therapy Introduction
11.9.4 Novartis Revenue in Immuno-Cell Therapy Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Osiris
11.10.1 Osiris Company Details
11.10.2 Osiris Business Overview
11.10.3 Osiris Immuno-Cell Therapy Introduction
11.10.4 Osiris Revenue in Immuno-Cell Therapy Business (2016-2021)
11.10.5 Osiris Recent Development
11.11 Vericel Corporation
11.11.1 Vericel Corporation Company Details
11.11.2 Vericel Corporation Business Overview
11.11.3 Vericel Corporation Immuno-Cell Therapy Introduction
11.11.4 Vericel Corporation Revenue in Immuno-Cell Therapy Business (2016-2021)
11.11.5 Vericel Corporation Recent Development
11.12 Fujifilm Cellular Dynamics
11.12.1 Fujifilm Cellular Dynamics Company Details
11.12.2 Fujifilm Cellular Dynamics Business Overview
11.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Introduction
11.12.4 Fujifilm Cellular Dynamics Revenue in Immuno-Cell Therapy Business (2016-2021)
11.12.5 Fujifilm Cellular Dynamics Recent Development
11.13 JCR Pharmaceuticals
11.13.1 JCR Pharmaceuticals Company Details
11.13.2 JCR Pharmaceuticals Business Overview
11.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Introduction
11.13.4 JCR Pharmaceuticals Revenue in Immuno-Cell Therapy Business (2016-2021)
11.13.5 JCR Pharmaceuticals Recent Development
11.14 Beike Biotechnology
11.14.1 Beike Biotechnology Company Details
11.14.2 Beike Biotechnology Business Overview
11.14.3 Beike Biotechnology Immuno-Cell Therapy Introduction
11.14.4 Beike Biotechnology Revenue in Immuno-Cell Therapy Business (2016-2021)
11.14.5 Beike Biotechnology Recent Development
11.15 Golden Meditech
11.15.1 Golden Meditech Company Details
11.15.2 Golden Meditech Business Overview
11.15.3 Golden Meditech Immuno-Cell Therapy Introduction
11.15.4 Golden Meditech Revenue in Immuno-Cell Therapy Business (2016-2021)
11.15.5 Golden Meditech Recent Development
11.16 Guanhao Biotech
11.16.1 Guanhao Biotech Company Details
11.16.2 Guanhao Biotech Business Overview
11.16.3 Guanhao Biotech Immuno-Cell Therapy Introduction
11.16.4 Guanhao Biotech Revenue in Immuno-Cell Therapy Business (2016-2021)
11.16.5 Guanhao Biotech Recent Development
11.17 Beroni Group
11.17.1 Beroni Group Company Details
11.17.2 Beroni Group Business Overview
11.17.3 Beroni Group Immuno-Cell Therapy Introduction
11.17.4 Beroni Group Revenue in Immuno-Cell Therapy Business (2016-2021)
11.17.5 Beroni Group Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Immuno-Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Passive Immune (NK, LAK etc)
Table 3. Key Players of Active Immune
Table 4. Global Immuno-Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Immuno-Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Immuno-Cell Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Immuno-Cell Therapy Market Share by Regions (2016-2021)
Table 8. Global Immuno-Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Immuno-Cell Therapy Market Share by Regions (2022-2027)
Table 10. Immuno-Cell Therapy Market Trends
Table 11. Immuno-Cell Therapy Market Drivers
Table 12. Immuno-Cell Therapy Market Challenges
Table 13. Immuno-Cell Therapy Market Restraints
Table 14. Global Immuno-Cell Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Immuno-Cell Therapy Market Share by Players (2016-2021)
Table 16. Global Top Immuno-Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-Cell Therapy as of 2020)
Table 17. Ranking of Global Top Immuno-Cell Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Immuno-Cell Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Immuno-Cell Therapy Product Solution and Service
Table 21. Date of Enter into Immuno-Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Immuno-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Immuno-Cell Therapy Revenue Market Share by Type (2016-2021)
Table 25. Global Immuno-Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Immuno-Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Immuno-Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Immuno-Cell Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global Immuno-Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Immuno-Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Immuno-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Immuno-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Immuno-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Immuno-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Immuno-Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Immuno-Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Immuno-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Immuno-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Immuno-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Immuno-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Immuno-Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Immuno-Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Immuno-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Immuno-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Immuno-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Immuno-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Immuno-Cell Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Immuno-Cell Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Immuno-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Immuno-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Immuno-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Immuno-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Immuno-Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Immuno-Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Immuno-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Immuno-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Immuno-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Immuno-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Immuno-Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Immuno-Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. MEDINET Co Company Details
Table 62. MEDINET Co Business Overview
Table 63. MEDINET Co Immuno-Cell Therapy Product
Table 64. MEDINET Co Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 65. MEDINET Co Recent Development
Table 66. Erytech Company Details
Table 67. Erytech Business Overview
Table 68. Erytech Immuno-Cell Therapy Product
Table 69. Erytech Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 70. Erytech Recent Development
Table 71. Seta Clinic Group Company Details
Table 72. Seta Clinic Group Business Overview
Table 73. Seta Clinic Group Immuno-Cell Therapy Product
Table 74. Seta Clinic Group Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 75. Seta Clinic Group Recent Development
Table 76. Takeda Company Details
Table 77. Takeda Business Overview
Table 78. Takeda Immuno-Cell Therapy Product
Table 79. Takeda Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 80. Takeda Recent Development
Table 81. SBI Holdings Company Details
Table 82. SBI Holdings Business Overview
Table 83. SBI Holdings Immuno-Cell Therapy Product
Table 84. SBI Holdings Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 85. SBI Holdings Recent Development
Table 86. Oxford BioTherapeutics Company Details
Table 87. Oxford BioTherapeutics Business Overview
Table 88. Oxford BioTherapeutics Immuno-Cell Therapy Product
Table 89. Oxford BioTherapeutics Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 90. Oxford BioTherapeutics Recent Development
Table 91. Fate Therapeutics Company Details
Table 92. Fate Therapeutics Business Overview
Table 93. Fate Therapeutics Immuno-Cell Therapy Product
Table 94. Fate Therapeutics Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 95. Fate Therapeutics Recent Development
Table 96. Gilead Sciences Company Details
Table 97. Gilead Sciences Business Overview
Table 98. Gilead Sciences Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 99. Gilead Sciences Recent Development
Table 100. Novartis Company Details
Table 101. Novartis Business Overview
Table 102. Novartis Immuno-Cell Therapy Product
Table 103. Novartis Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 104. Novartis Recent Development
Table 105. Osiris Company Details
Table 106. Osiris Business Overview
Table 107. Osiris Immuno-Cell Therapy Product
Table 108. Osiris Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 109. Osiris Recent Development
Table 110. Vericel Corporation Company Details
Table 111. Vericel Corporation Business Overview
Table 112. Vericel Corporation Immuno-Cell Therapy Product
Table 113. Vericel Corporation Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 114. Vericel Corporation Recent Development
Table 115. Fujifilm Cellular Dynamics Company Details
Table 116. Fujifilm Cellular Dynamics Business Overview
Table 117. Fujifilm Cellular Dynamics Immuno-Cell Therapy Product
Table 118. Fujifilm Cellular Dynamics Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 119. Fujifilm Cellular Dynamics Recent Development
Table 120. JCR Pharmaceuticals Company Details
Table 121. JCR Pharmaceuticals Business Overview
Table 122. JCR Pharmaceuticals Immuno-Cell Therapy Product
Table 123. JCR Pharmaceuticals Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 124. JCR Pharmaceuticals Recent Development
Table 125. Beike Biotechnology Company Details
Table 126. Beike Biotechnology Business Overview
Table 127. Beike Biotechnology Immuno-Cell Therapy Product
Table 128. Beike Biotechnology Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 129. Beike Biotechnology Recent Development
Table 130. Golden Meditech Company Details
Table 131. Golden Meditech Business Overview
Table 132. Golden Meditech Immuno-Cell Therapy Product
Table 133. Golden Meditech Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 134. Golden Meditech Recent Development
Table 135. Guanhao Biotech Company Details
Table 136. Guanhao Biotech Business Overview
Table 137. Guanhao Biotech Immuno-Cell Therapy Product
Table 138. Guanhao Biotech Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 139. Guanhao Biotech Recent Development
Table 140. Beroni Group Company Details
Table 141. Beroni Group Business Overview
Table 142. Beroni Group Immuno-Cell Therapy Product
Table 143. Beroni Group Revenue in Immuno-Cell Therapy Business (2016-2021) & (US$ Million)
Table 144. Beroni Group Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-Cell Therapy Market Share by Type: 2020 VS 2027
Figure 2. Passive Immune (NK, LAK etc) Features
Figure 3. Active Immune Features
Figure 4. Global Immuno-Cell Therapy Market Share by Application: 2020 VS 2027
Figure 5. Oncology Case Studies
Figure 6. Cardiovascular Disease (CVD) Case Studies
Figure 7. Orthopedic Case Studies
Figure 8. Wound Healing Case Studies
Figure 9. Others Case Studies
Figure 10. Immuno-Cell Therapy Report Years Considered
Figure 11. Global Immuno-Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Immuno-Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Immuno-Cell Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Immuno-Cell Therapy Market Share by Regions (2022-2027)
Figure 15. Global Immuno-Cell Therapy Market Share by Players in 2020
Figure 16. Global Top Immuno-Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-Cell Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Immuno-Cell Therapy Revenue in 2020
Figure 18. Global Immuno-Cell Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Immuno-Cell Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Immuno-Cell Therapy Market Share by Type (2016-2027)
Figure 22. North America Immuno-Cell Therapy Market Share by Application (2016-2027)
Figure 23. North America Immuno-Cell Therapy Market Share by Country (2016-2027)
Figure 24. United States Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Immuno-Cell Therapy Market Share by Type (2016-2027)
Figure 28. Europe Immuno-Cell Therapy Market Share by Application (2016-2027)
Figure 29. Europe Immuno-Cell Therapy Market Share by Country (2016-2027)
Figure 30. Germany Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Immuno-Cell Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Immuno-Cell Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Immuno-Cell Therapy Market Share by Region (2016-2027)
Figure 40. China Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Immuno-Cell Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Immuno-Cell Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Immuno-Cell Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Immuno-Cell Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Immuno-Cell Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Immuno-Cell Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Immuno-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. MEDINET Co Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 60. Erytech Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 61. Seta Clinic Group Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 62. Takeda Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 63. SBI Holdings Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 64. Oxford BioTherapeutics Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 65. Fate Therapeutics Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 66. Gilead Sciences Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 68. Osiris Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 69. Vericel Corporation Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 70. Fujifilm Cellular Dynamics Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 71. JCR Pharmaceuticals Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 72. Beike Biotechnology Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 73. Golden Meditech Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 74. Guanhao Biotech Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 75. Beroni Group Revenue Growth Rate in Immuno-Cell Therapy Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

以下、関連資料のご紹介

世界の自己細胞療法市場規模・現状・予測（2021年-2027年）

Global Autologous Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3873 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、自己細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（骨髄、表皮）、用途別市場規模（神経内科、整形外科、がん、創傷治癒、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のT細胞療法市場規模・現状・予測（2021年-2027年）

Global T-Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4937 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、T細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CAR T細胞療法、TCR療法、TIL療法）、用途別市場規模（病院、診療所・外来センター、がん研究所、その他）、主要地域別市場規模（北米、アメ...

世界の細胞治療技術市場規模・現状・予測（2021年-2027年）

Global Cell Therapy Technologies Market Size, Status and Forecast 2021-2027
QFJ1-3991 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、細胞治療技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、消耗品、その他）、用途別市場規模（人間用、動物用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南ア...

世界の細胞治療バイオプロセス市場規模・現状・予測（2021年-2027年）

Global Cell Therapy Bioprocessing Market Size, Status and Forecast 2021-2027
QFJ1-3990 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、細胞治療バイオプロセスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫細胞、ヒト胚性幹細胞、多能性幹細胞幹細胞、造血幹細胞）、用途別市場規模（心血管疾患（CVD）、腫瘍学、創傷治癒、整形外科、そ...

世界の胎盤幹細胞療法市場規模・現状・予測（2021年-2027年）

Global Placental Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5306 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、胎盤幹細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液悪性腫瘍・障害、先天性免疫不全障害、代謝障害、神経障害、その他）、用途別市場規模（病院・専門クリニック、臨床研究機関、研究機関・学術、...

世界の免疫腫瘍学アッセイ市場規模・現状・予測（2021年-2027年）

Global Immuno Oncology Assays Market Size, Status and Forecast 2021-2027
QFJ1-4349 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、免疫腫瘍学アッセイの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イムノアッセイ、フローサイトメトリー、PCR、次世代シーケンシング）、用途別市場規模（研究所、臨床診断）、主要地域別市場規模（北米、ア...

世界の同種異系幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Allogeneic Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3781 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、同種異系幹細胞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（成体幹細胞治療、ヒト胚性幹細胞治療、人工多能性幹細胞治療、その他）、用途別市場規模（筋骨格系障害、傷＆怪我、心血管疾患、その他）、主要...

世界の細胞・遺伝子治療用ツール＆試薬市場規模・現状・予測（2021年-2027年）

Global Cell and Gene Therapy Tools and Reagents Market Size, Status and Forecast 2021-2027
QFJ1-5121 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、細胞・遺伝子治療用ツール＆試薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学発光免疫測定法（CLIA）、フルオロイムノアッセイ、マルチプレックスアッセイ、迅速診断技術）、用途別市場規模（病院、研...

世界の個別化細胞療法市場規模・現状・予測（2021年-2027年）

Global Personalized Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4691 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、個別化細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（造血幹細胞、骨格筋幹細胞、間葉系幹細胞、リンパ球、その他）、用途別市場規模（循環器疾患、神経疾患、炎症性疾患、糖尿病、がん、その他）、主要...

世界の細胞＆遺伝子治療製造QC市場規模・現状・予測（2021年-2027年）

Global Cell and Gene Therapy Manufacturing QC Market Size, Status and Forecast 2021-2027
QFJ1-3986 2021年6月 119Pages
QYResearch社発行の本調査レポートでは、細胞＆遺伝子治療製造QCの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（安全性試験、純度試験、効力試験、同一性試験、安定性試験）、用途別市場規模（精密治療、生物研究所）、主要地域別市場規模（北米、アメ...

世界の免疫腫瘍学アッセイ市場規模・現状・予測（2021年-2027年） Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoin…
世界の細胞治療バイオプロセス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cell Therapy Bioprocessing Market The global Cell Therapy Bioprocessing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …
世界の自己細胞療法市場規模・現状・予測（2021年-2027年） Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is t…
世界の細胞治療処理市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cell therapy Processing Market The global Cell therapy Processing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…
世界のT細胞療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global T-Cell Therapy Market The global T-Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…